04:59 PM EDT, 05/01/2025 (MT Newswires) -- Yann Mazabraud, Executive Vice President, Head of International, on April 29, 2025, sold 6,745 shares in Rhythm Pharmaceuticals ( RYTM ) for $438,946. Following the Form 4 filing with the SEC, Mazabraud has control over a total of 37,655 common shares of the company, with 37,655 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925043555/xslF345X05/tm2513769-1_4seq1.xml